Topaz Biosciences, Inc. — Form D
Topaz Biosciences, Inc. of Emeryville, CA, a company, filed a Form D exempt-offering notice with the SEC on 2025-03-25. The offering totals $3.2M, of which $1.4M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2025-03-25
- Form: D
- Accession: 0002062605-25-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.2M
- Amount sold: $1.4M
- Remaining: $1.7M
- Investors: 8
- Date of first sale: 2025-03-11
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-542023
Issuer
- Name: Topaz Biosciences, Inc.
- CIK: 0002062605
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 1250 45th Street, Suite 320, Emeryville, CA, 94608
- Phone: 415-572-3901
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Oliver Liu | Director | Emeryville, CA |
| Jennifer Shock | Director | Emeryville, CA |
| Teresa Shock | Director | Emeryville, CA |
| Caroline Hadfield | Executive Officer | Emeryville, CA |
| Oliver Liu | Executive Officer | Emeryville, CA |
| Jennifer Shock | Executive Officer | Emeryville, CA |
More